ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1

CUSIP: 00484MAA4

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Debt / NOTE 1.750% 6/1
Market price (% of par)
76.0%
Total 13F principal
$329,329,000
Principal change
-$2,992,000
Total reported market value
$250,488,000
Number of holders
44
Value change
-$3,213,253
Number of buys
21
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 00484MAA4?
CUSIP 00484MAA4 identifies 00484MAA4 - ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 as of Q4 2016

As of 31 Dec 2016, ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 was held by 44 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $329,329,000 in principal (par value) of the bond. The largest 10 bondholders included BAKER BROS. ADVISORS LP, UBS OCONNOR LLC, CNH PARTNERS LLC, ANGELO GORDON & CO., L.P., WOLVERINE ASSET MANAGEMENT LLC, Davidson Kempner Capital Management LP, D. E. Shaw & Co., Inc., CITADEL ADVISORS LLC, CAMDEN ASSET MANAGEMENT L P /CA, and AMERIPRISE FINANCIAL INC. This page lists 44 institutional bondholders reporting positions for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.